DAGCO Inc’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.32M | Sell |
2,636
-315
| -11% | -$151K | 0.24% | 58 |
|
|
2026
Q1 | $1.45M | Sell |
2,951
-104
| -3% | -$56.4K | 0.31% | 47 |
|
|
2025
Q4 | $1.77M | Sell |
3,055
-15
| -0.5% | -$8.48K | 0.41% | 41 |
|
|
2025
Q3 | $1.49M | Hold |
3,070
| – | – | 0.37% | 42 |
|
|
2025
Q2 | $1.24M | Sell |
3,070
-280
| -8% | -$117K | 0.35% | 42 |
|
|
2025
Q1 | $1.67M | Sell |
3,350
-111
| -3% | -$60.1K | 0.54% | 35 |
|
|
2024
Q4 | $1.8M | Buy |
3,461
+85
| +3% | +$46.7K | 0.6% | 34 |
|
|
2024
Q3 | $2.09M | Sell |
3,376
-194
| -5% | -$115K | 0.86% | 29 |
|
|
2024
Q2 | $1.97M | Hold |
3,570
| – | – | 0.88% | 29 |
|
|
2024
Q1 | $2.07M | Buy |
3,570
+2,920
| +449% | +$1.64M | 0.94% | 30 |
|
|
2023
Q4 | $345K | Sell |
650
-4,300
| -87% | -$2.08M | 0.32% | 37 |
|
|
2023
Q3 | $370K | Buy |
4,950
+1,022
| +26% | +$545K | 0.19% | 62 |
|
|
2023
Q2 | $2.05M | Sell |
3,928
-115
| -3% | -$62.1K | 1.02% | 28 |
|
|
2023
Q1 | $2.33M | Sell |
4,043
-42
| -1% | -$23.7K | 1.25% | 25 |
|
|
2022
Q4 | $2.25M | Sell |
4,085
-55
| -1% | -$29.1K | 1.31% | 21 |
|
|
2022
Q3 | $2.1M | Sell |
4,140
-149
| -3% | -$83.4K | 1.32% | 21 |
|
|
2022
Q2 | $2.33M | Sell |
4,289
-40
| -0.9% | -$22K | 1.2% | 23 |
|
|
2022
Q1 | $2.48M | Sell |
4,329
-13
| -0.3% | -$7.47K | 1.13% | 24 |
|
|
2021
Q4 | $2.9M | Sell |
4,342
-110
| -2% | -$68.7K | 1.14% | 30 |
|
|
2021
Q3 | $2.54M | Hold |
4,452
| – | – | 1.09% | 29 |
|
|
2021
Q2 | $2.25M | Sell |
4,452
-120
| -3% | -$56.6K | 1% | 32 |
|
|
2021
Q1 | $2.09M | Buy |
4,572
+92
| +2% | +$43.9K | 1.04% | 31 |
|
|
2020
Q4 | $2.09M | Sell |
4,480
-125
| -3% | -$58.6K | 1.16% | 27 |
|
|
2020
Q3 | $2.03M | Sell |
4,605
-190
| -4% | -$78.5K | 1.37% | 22 |
|
|
2020
Q2 | $1.74M | Sell |
4,795
-15
| -0.3% | -$5.03K | 1.75% | 18 |
|
|
2020
Q1 | $1.36M | Sell |
4,810
-90
| -2% | -$28.4K | 1.48% | 20 |
|
|
2019
Q4 | $1.59M | Buy |
4,900
+55
| +1% | +$16.7K | 1.41% | 23 |
|
|
2019
Q3 | $1.41M | Buy |
4,845
+150
| +3% | +$43K | 1.41% | 22 |
|
|
2019
Q2 | $1.38M | Sell |
4,695
-55
| -1% | -$15.1K | 1.45% | 21 |
|
|
2019
Q1 | $1.3M | Sell |
4,750
-25
| -0.5% | -$6.22K | 1.4% | 23 |
|
|
2018
Q4 | $1.07M | Buy |
+4,775
| New | +$1.12M | 1.33% | 27 |
|
Other funds holding TMO
DAGCO Inc's TMO Position: Q2 2026 in Review
DAGCO Inc reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $151K and leaving 2,636 shares worth $1.32M. The position accounts for 0.24% of the portfolio, ranked #58.
DAGCO Inc first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.9M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- DAGCO Inc held 2,636 shares of Thermo Fisher Scientific worth $1.32M as of Q2 2026.
- DAGCO Inc sold 315 Thermo Fisher Scientific shares in Q2 2026, an estimated $151K.
- Thermo Fisher Scientific made up 0.24% of DAGCO Inc's portfolio in Q2 2026, its #58 holding.
- DAGCO Inc first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
- DAGCO Inc's Thermo Fisher Scientific position peaked at $2.9M in Q4 2021.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on DAGCO Inc's 13F filing for Q2 2026, filed 10 Jul 2026.